Expression Atlas of FGF and FGFR Genes in Pancancer Uncovered Predictive Biomarkers for Clinical Trials of Selective FGFR Inhibitors

BACKGROUND: Clinical trials based on FGFR mutation or amplification as a druggable target of FGFR inhibitors have produced disappointing clinical outcomes. Therefore, the identification of predictive biomarkers for FGFR-targeted agents has remained a crucial issue. METHODS: Expression profiles of FG...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Wu, Long, Tao, Weiping, Wu, Dawei, Ma, Fei, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293733/
https://www.ncbi.nlm.nih.gov/pubmed/32596330
http://dx.doi.org/10.1155/2020/5658904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293733/
https://www.ncbi.nlm.nih.gov/pubmed/32596330
http://dx.doi.org/10.1155/2020/5658904

Ejemplares similares